PERISPLENITIS

PERISPLENITIS was reported 2 times

PERISPLENITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 1 0.0000
1 Leukocyte Growth Factor [EPC] 1 0.0000
2 Endothelin Receptor Antagonist [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000